Design, synthesis and evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylates as potential anticonvulsants and their molecular properties prediction.

doi:10.1016/j.ejmech.2013.06.006

Paper

DOI: 10.1016/j.ejmech.2013.06.006

Design, synthesis and evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylates as potential anticonvulsants and their molecular properties prediction.

Published Aug 1, 2013 · G. Prasanthi, K. Prasad, K. Bharathi

European journal of medicinal chemistry

Q2 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Study Snapshot

Dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylate derivatives show potential anticonvulsant and

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1016/j.bmc.2012.04.002

Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides.

N-benzyl 2-amino-2-(hetero)aromatic acetamides show potent anticonvulsant activity and notable neuropathic pain-attenuating properties when the terminal 2-acetyl group is removed.

2012·15citations·P. Baruah et al.·Bioorganic & medicinal chemistry

Bioorganic & medicinal chemistry

DOI: 10.1016/j.eplepsyres.2011.10.005

Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue

DEVA, a prodrug of valproic acid, shows more potent anticonvulsant activity than VPA, while DEVAMIDE is more potent than DEVA in the rat-MES test.

2012·7citations·Tawfeeq Shekh-Ahmad et al.·Epilepsy Research

Epilepsy Research

DOI: 10.1016/j.bmcl.2011.10.057

Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.

Novel 1,3,4-oxadiazole analogues show potential as potent antimicrobial and antitubercular agents, with compound 4a showing comparable activity to ciprofloxacin against bacteria and compounds 4e and 4k showing antifungal activity.

2011·170citations·M. Ahsan et al.·Bioorganic & medicinal chemistry letters

Bioorganic & medicinal chemistry letters

DOI: 10.1016/j.ejmech.2011.09.026

Hantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents.

New 1,4-dihydropyridine derivatives show potent antibacterial and antioxidant properties, with compounds 4c, 4e, and 4f being safe up to 3000 mg/kg and no animal deaths, while compound 4f has significant mortality and behavioral changes.

2011·126citations·A. M. Vijesh et al.·European journal of medicinal chemistry

European journal of medicinal chemistry

DOI: 10.1016/j.yebeh.2011.08.026

Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid

N-methoxy-valnoctamide (N-methoxy-VCD) shows better anticonvulsant activity than valproic acid and is a promising candidate for further evaluation as a new central nervous system drug.

2011·9citations·N. Pessah et al.·Epilepsy & Behavior

Epilepsy & Behavior

Citations

DOI: 10.1039/d4ra06121g

New triazole-based hybrids as neurotropic agents

New triazole-based hybrids show anticonvulsive, anxiolytic, and antidepressant properties, with the most active compounds having a pyrano[3,4-c]pyridine ring in their structure.

2024·0citations·S. Sirakanyan et al.·RSC Advances

RSC Advances

DOI: 10.3390/futurepharmacol4030031

Anticancer Activity of 4-Aryl-1,4-Dihydropyridines

Symmetric 1,4-DHPs 18, 19, and 20 show potential as novel lead compounds for discovering other 1,4-DHP derivatives with improved anticancer potency and selectivity.

2024·0citations·Thaís A. S. Oliveira et al.·Future Pharmacology

Future Pharmacology

DOI: 10.1111/cbdd.14498

Synthesis, in silico screening, and biological evaluation of novel pyridine congeners as anti‐epileptic agents targeting AMPA (α‐amino‐3‐hydroxy‐5‐methylisoxazole) receptors

Novel pyridine congeners show potential as anti-epileptic drugs targeting AMPA receptors, with 60% protection against epileptic seizures compared to 59% protection by regular phenytoin.

2024·0citations·Shivani Tyagi et al.·Chemical Biology & Drug Design

Chemical Biology & Drug Design

DOI: 10.1080/00268976.2023.2200845

Synthesis, crystal structure, Hirshfeld surface, biological evaluation, DFT and molecular docking studies of unsymmetrical 3-allyl-5-ethyl-1,4-dihydro-2,6-dimethyl-4-phenyl pyridine-3,5-dicarboxylate derivatives

The compounds synthesized using ceric ammonium nitrate show promising antimicrobial properties and could be considered for further drug design efforts.

2023·4citations·K. Arulvani et al.·Molecular Physics

Molecular Physics

DOI: 10.1021/acs.jmedchem.2c01818

Mechanistic Insight of Synthesized 1,4-Dihydropyridines as an Antidiabetic Sword against Reactive Oxygen Species.

Compound 8b shows the most prominent antidiabetic effect, reducing blood glucose by -glucosidase inhibition and reducing reactive oxygen species in -cells and muscle cells simultaneously.

2022·7citations·Peter A. Sidhom et al.·Journal of medicinal chemistry

Journal of medicinal chemistry